Dutch SME offers expertise through consultancy services to companies in need of expertise in biotechnology, including bio nanotechnologies and bioorganic chemistry combined with business development.
A Dutch SME provides advice on technical and business development, due diligence, evaluation of proposals, IP issues and development of strategic R&D partnerships in the area of life sciences and health. The SME has been working successfully for more than 15 years in this field and is offering its services to Dutch and foreign companies, through a services agreement.
This SME is independent but a very well connected company with more than 15 years of experience. The company is a member of the Netherlands Biotech branch organization and is the National representative of the European Association for Predictive, Preventive and Personalized Medicine’(PPPM). The consultant has a PhD degree in chemistry of biologically active compounds and a Dr.Sc. degree in biotechnology including bio nanotechnologies and in bioorganic chemistry. The company has developed a patented technology that is validated in cooperation with several universities and has experienced by itself the opportunities and threats of cooperation between national and international public and private partners. Born and raised in Russia but spending most of her professional life in the Netherlands, the consultant has a good understanding of intercultural differences that can complicate strategic partnerships. The consultant is invited speaker for more than 50 international conferences.
This Dutch SME provides expert advice on technical (project management) and business development aspects, due diligence (technology assessment, SWOT analysis), evaluation of proposals (for either research or investments), IP-related issues (investigation of freedom-to-operate, conducting patent search, identification unique selling points) and development of strategic R&D partnerships in the area of life sciences and health. Together with its independent partners the company can also conduct all the related steps in licensing, including the value assessment, term sheet and license agreement negotiation, freedom-to-operate analysis, etc. The team members are deal-makers and can use all their creativity to respond adequately to the counter party to make a win-win deal happen. The consulting could very effectively screen business opportunities for specific needs of the client in the (nano) biotechnology area. This is due to the intensive knowledge in the field and own experience in negotiating of a whole range of national and international contracts, most of them related to the IP-issues, technology transfer and joint products development. The SME based at the Leiden Science Park in The Netherlands which is well-known for its expertise in life sciences. The company focusses on life science and health, agro-food and expanded to the bio-based economy. As an independent research oriented technology platform, the company's major ambition is to contribute to the challenges of preventive, predictive and personalized medicine (PPPM) and to develop novel technologies for the pharmaceutical and the food & nutrition market. The company offers a services agreements to industry (large or small companies) and universities. Typical partners are investors with a need to access prospects of new technology or funding organisations that need technical expertise to rate funding proposals. Requests of biotech for evaluation of in- and out- licensing of specific technology are coming frequently on board.
06002001Oil, gas and coal
06004Enhanced Oil Recovery (EOI)
05007005Hospital and other institutional management
05008002Food and feed ingredients
M.70.2.2Business and other management consultancy activities
M.72.1.1Research and experimental development on biotechnology
M.74.9.0Other professional, scientific and technical activities n.e.c.
This companies is looking for partners in industry (large or small companies) and universities that are in need of expertise in biotechnology including bio nanotechnologies and in bioorganic chemistry combined with business development. Typical partners are - investors with a need to access the prospects of new technology or technologies; - funding organisations that need technical expertise to rate funding proposals.; - biotech companies that are seeking for technological and economical SWOT analysis within the in- or out licensing of technologies and due-diligence context.
SME 11-50,University,R&D Institution,SME <10,>500 MNE,251-500,SME 51-250,>500
Already on the market
Bio Chem Tech
Industry SME <= 10
English Dutch Russian